Breast cancer and hormone-replacement therapy: the Million Women Study

Sarah Gray

doi:10.1016/s0140-6736(03)14598-9

Breast cancer and hormone-replacement therapy: the Million Women Study

Sarah Gray

In: The Lancet · 2003 · vol. 362(9392) , pp. 1332 · doi:10.1016/s0140-6736(03)14598-9 · PMID:14575993 · W3144959505

letter OA: bronze CC0 ⤵ 1 in-corpus citation

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-10 ⓘ

The Million Women Study investigated the association between hormone replacement therapy and breast cancer risk, finding an increased risk with current use.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1 mg estradiol valerate/2 mg dienogest on hot flushes in postmenopausal women 2007

References (2)

W2047081988 via openalex
W2061362051 via openalex

Cited by (1)

A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1 mg estradiol valerate/2 mg dienogest on hot flushes in postmenopausal women 2007

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] W2047081988 via openalex

[2] W2061362051 via openalex